Respiratory failure due to infliximab induced interstitial lung disease.
|
| Abstract |
Although poorly understood, interstitial lung disease has been reported as a possible complication of tumor necrosis factor alpha inhibitors. We report a case of interstitial lung disease in a 64-year-old man with psoriasis 3 weeks after the initiation of infliximab treatment. The patient had received two fortnightly infusions of infliximab following a short course of methotrexate. Thoracic computed tomography showed bilateral ground glass and interstitial infiltrates, while the results of microbiology and immunologic workup were negative. Likewise, bronchoalveolar lavage detected neither typical nor atypical pathogens. Infliximab-induced interstitial lung injury was suspected and corticosteroid therapy was administered which resulted in rapid clinical and radiological improvement. This is one of the few reported cases of interstitial lung disease due to infliximab in the psoriasis population. The patient had no pre-existing lung pathology, while his previous exposure to methotrexate was minimal and was not temporally associated with the induction of interstitial lung disease.
|
|---|---|
| Authors | Sotiris Kakavas, Evangelos Balis, Vasiliki Lazarou, Marousa Kouvela, Georgios Tatsis |
| Journal | Heart & lung : the journal of critical care (Heart Lung) 2013 Nov-Dec Vol. 42 Issue 6 Pg. 480-2 ISSN: 1527-3288 [Electronic] United States |
| PMID | 23969008 (Publication Type: Case Reports, Journal Article) |
| Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!